packageCetuximab

cetuximab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Cetuximab is a monoclonal antibody used to treat several cancers, mainly head and neck cancers and colorectal cancers. It is approved and authorised in the European Union, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q420296 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:cetuximab
ATC codes:L01FE01
DrugBank:DB00002
Wikidata:Q420296
molar mass:145782 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown